369 related articles for article (PubMed ID: 14676676)
21. Complement-induced impairment of innate immunity during sepsis.
Huber-Lang MS; Younkin EM; Sarma JV; McGuire SR; Lu KT; Guo RF; Padgaonkar VA; Curnutte JT; Erickson R; Ward PA
J Immunol; 2002 Sep; 169(6):3223-31. PubMed ID: 12218141
[TBL] [Abstract][Full Text] [Related]
22. C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist.
Bao L; Osawe I; Puri T; Lambris JD; Haas M; Quigg RJ
Eur J Immunol; 2005 Aug; 35(8):2496-506. PubMed ID: 16052609
[TBL] [Abstract][Full Text] [Related]
23. Increased C5a receptor expression in sepsis.
Riedemann NC; Guo RF; Neff TA; Laudes IJ; Keller KA; Sarma VJ; Markiewski MM; Mastellos D; Strey CW; Pierson CL; Lambris JD; Zetoune FS; Ward PA
J Clin Invest; 2002 Jul; 110(1):101-8. PubMed ID: 12093893
[TBL] [Abstract][Full Text] [Related]
24. The dark side of C5a in sepsis.
Ward PA
Nat Rev Immunol; 2004 Feb; 4(2):133-42. PubMed ID: 15040586
[TBL] [Abstract][Full Text] [Related]
25. Weak response of porcine C5a receptor towards human C5a in miniature pig endothelial cells and PMNs.
Yi KS; Lee S; Kang YH; Bae YS; Hwang SY; Ha I; Kim H; Kim MS; Cho B; Kang HJ; Bang KT; Kim JY; Yang J; Chung J; Ahn C
Xenotransplantation; 2007 Nov; 14(6):563-71. PubMed ID: 17991144
[TBL] [Abstract][Full Text] [Related]
26. Role of the complement in experimental sepsis.
Ward PA
J Leukoc Biol; 2008 Mar; 83(3):467-70. PubMed ID: 17875813
[TBL] [Abstract][Full Text] [Related]
27. Protective effects of IL-6 blockade in sepsis are linked to reduced C5a receptor expression.
Riedemann NC; Neff TA; Guo RF; Bernacki KD; Laudes IJ; Sarma JV; Lambris JD; Ward PA
J Immunol; 2003 Jan; 170(1):503-7. PubMed ID: 12496437
[TBL] [Abstract][Full Text] [Related]
28. Different endocytosis pathways of the C5a receptor and the N-formyl peptide receptor.
Suvorova ES; Gripentrog JM; Miettinen HM
Traffic; 2005 Feb; 6(2):100-15. PubMed ID: 15634211
[TBL] [Abstract][Full Text] [Related]
29. Regulation of IL-8 production by complement-activated product, C5a, in vitro and in vivo during sepsis.
Wang L; Han G; Wang R; Chen G; Xu R; Xiao H; Li X; Geng S; Li Y; Li X; Wang J; Feng J; Riedemann NC; Guo R; Shen B; Li Y
Clin Immunol; 2010 Oct; 137(1):157-65. PubMed ID: 20591742
[TBL] [Abstract][Full Text] [Related]
30. Liu-Shen-Wan, a traditional Chinese medicine, improves survival in sepsis induced by cecal ligation and puncture via reducing TNF-alpha levels, MDA content and enhancing macrophage phagocytosis.
Ma H; Kou J; Zhu D; Yan Y; Yu B
Int Immunopharmacol; 2006 Aug; 6(8):1355-62. PubMed ID: 16782549
[TBL] [Abstract][Full Text] [Related]
31. Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor.
Morgan EL; Ember JA; Sanderson SD; Scholz W; Buchner R; Ye RD; Hugli TE
J Immunol; 1993 Jul; 151(1):377-88. PubMed ID: 8326131
[TBL] [Abstract][Full Text] [Related]
32. Identification of a new class of small molecule C5a receptor antagonists.
Chen JJ; Cole DC; Ciszewski G; Crouse K; Ellingboe JW; Nowak P; Tawa GJ; Berstein G; Li W
Bioorg Med Chem Lett; 2010 Jan; 20(2):662-4. PubMed ID: 20004096
[TBL] [Abstract][Full Text] [Related]
33. Biologically active conformer of the effector region of human C5a and modulatory effects of N-terminal receptor binding determinants on activity.
Finch AM; Vogen SM; Sherman SA; Kirnarsky L; Taylor SM; Sanderson SD
J Med Chem; 1997 Mar; 40(6):877-84. PubMed ID: 9083476
[TBL] [Abstract][Full Text] [Related]
34. Complement C5a Functions as a Master Switch for the pH Balance in Neutrophils Exerting Fundamental Immunometabolic Effects.
Denk S; Neher MD; Messerer DAC; Wiegner R; Nilsson B; Rittirsch D; Nilsson-Ekdahl K; Weckbach S; Ignatius A; Kalbitz M; Gebhard F; Weiss ME; Vogt J; Radermacher P; Köhl J; Lambris JD; Huber-Lang MS
J Immunol; 2017 Jun; 198(12):4846-4854. PubMed ID: 28490576
[TBL] [Abstract][Full Text] [Related]
35. Sepsis, apoptosis and complement.
Ward PA
Biochem Pharmacol; 2008 Dec; 76(11):1383-8. PubMed ID: 18848819
[TBL] [Abstract][Full Text] [Related]
36. Real-Time Imaging of Interactions of Neutrophils with Cryptococcus neoformans Demonstrates a Crucial Role of Complement C5a-C5aR Signaling.
Sun D; Zhang M; Liu G; Wu H; Zhu X; Zhou H; Shi M
Infect Immun; 2016 Jan; 84(1):216-29. PubMed ID: 26502909
[TBL] [Abstract][Full Text] [Related]
37. Regulatory role of C5a on macrophage migration inhibitory factor release from neutrophils.
Riedemann NC; Guo RF; Gao H; Sun L; Hoesel M; Hollmann TJ; Wetsel RA; Zetoune FS; Ward PA
J Immunol; 2004 Jul; 173(2):1355-9. PubMed ID: 15240730
[TBL] [Abstract][Full Text] [Related]
38. Probing the human receptor for C5a anaphylatoxin with site-directed antibodies. Identification of a potential ligand binding site on the NH2-terminal domain.
Oppermann M; Raedt U; Hebell T; Schmidt B; Zimmermann B; Götze O
J Immunol; 1993 Oct; 151(7):3785-94. PubMed ID: 8376805
[TBL] [Abstract][Full Text] [Related]
39. C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis.
Schreiber A; Xiao H; Jennette JC; Schneider W; Luft FC; Kettritz R
J Am Soc Nephrol; 2009 Feb; 20(2):289-98. PubMed ID: 19073822
[TBL] [Abstract][Full Text] [Related]
40. Receptors for complement C5a. The importance of C5aR and the enigmatic role of C5L2.
Lee H; Whitfeld PL; Mackay CR
Immunol Cell Biol; 2008 Feb; 86(2):153-60. PubMed ID: 18227853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
